EPAS1 and neoplasm: Remarkably, HIF2α mutations appear to be restricted to PPGLs, whereas they are mostly absent in tumor samples of other tumor entities included in The Cancer Genome Atlas (TCGA) and Genomics Evidence Neoplasia Information Exchange (GENIE) databases (117).